Nora Sundahl

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Nora Sundahl, Aurélie De Bruycker, Valerie Fonteyne (UGent) , Ellen De Paepe (UGent) , Carlos De Wagter (UGent) , Lynn Vanhaecke (UGent) and Piet Ost (UGent)

(2023) RADIOTHERAPY AND ONCOLOGY. 189.

Add to list

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213

Add to list

Journal Article
A1
open access

Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Roos Colman (UGent) , Wim Schrauwen (UGent) , Paulien West (UGent) , Nele Vandemaele (UGent) , Aglaja De Pauw (UGent) , Celine Jacobs (UGent) , Ingeborg Hilderson, Michael Saerens (UGent) , et al.

(2022) CANCERS. 14(4).

Add to list

Journal Article
A1
open access

Radiotherapy for oligometastatic non-small cell lung cancer : a narrative review

Nora Sundahl and Yolande Lievens (UGent)

(2021) TRANSLATIONAL LUNG CANCER RESEARCH. 10(7). p.3420-3431

Add to list

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas (UGent) , Nora Sundahl, Sylvie Rottey (UGent) , VIBEKE KRUSE (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Piet Dirix, Veerle Surmont (UGent) , Yolande Lievens (UGent) , Robin Van den Begin, et al.

(2021) ESTRO 2021, Abstracts. 161(S1). p.S490-S491

Add to list

Journal Article
A1
open access

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel Meireson, Liesbeth Ferdinande (UGent) , Marc Haspeslagh (UGent) , Benjamin Hennart, Delphine Allorge, Piet Ost (UGent) , Nora Sundahl, Mathieu Spaas (UGent) , Annelies Demeyer (UGent) and Lieve Brochez (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 12.

Add to list

Journal Article
A1
open access

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson, Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).

Add to list

Journal Article
A1
open access

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel Meireson, Simon Tavernier (UGent) , Sofie Van Gassen (UGent) , Nora Sundahl, Annelies Demeyer (UGent) , Mathieu Spaas (UGent) , Vibeke Kruse (UGent) , Liesbeth Ferdinande (UGent) , Jo Van Dorpe (UGent) , Benjamin Hennart, et al.

(2021) CANCERS. 13(11).

Add to list

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora Sundahl, Teofila Seremet, Jo Van Dorpe (UGent) , Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Lieve Brochez (UGent) , Vibeke Kruse (UGent) and Piet Ost (UGent)

(2019) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 104(4). p.828-835

Add to list

Journal Article
A1
open access

Inter-professional collaboration reduces the burden of caring for patients with mental illnesses in primary healthcare. A realist evaluation study

Marieke De Sutter, An De Sutter (UGent) , Nora Sundahl, Tom Declercq (UGent) and Peter Decat (UGent)

(2019) European Journal of General Practice. 25(4). p.236-242

Academic Bibliography

Nora Sundahl

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Radiotherapy for oligometastatic non-small cell lung cancer : a narrative review

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Inter-professional collaboration reduces the burden of caring for patients with mental illnesses in primary healthcare. A realist evaluation study

Contents

Support

Contact